Public-registry site landscape for NCT07260877, a Cutaneous Lupus Erythematosus (CLE) study sponsored by Ventus Therapeutics U.S., Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07260877 (registry record) |
| Sponsor | Ventus Therapeutics U.S., Inc. |
| Condition(s) | Cutaneous Lupus Erythematosus (CLE); Systemic Lupus Erythematosus; SLE; SLE (Systemic Lupus) |
| Phase | PHASE2 |
| Listed sites | 32 |
| Site countries | United States, Bulgaria, France, Georgia, Hungary, Poland, South Africa, Spain |
Eichor generates a preliminary site-risk snapshot for NCT07260877 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →